ADVENT On Air

Breath, Blood, and Beyond: The Prognostic Power of Biomarkers in Asthma Across Ages

2026-01-30

Join pediatric respirologist Dr. Sharon Dell and adult respirologist Dr. Simon Couillard as they discuss the prognostic and diagnostic power of asthma biomarkers and their impact on optimizing patient management across all ages.



ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. 



This podcast is intended for healthcare professionals only.



Disclaimer:


This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program

The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits




Speaker disclosures: 

Dr. Simon Couillard: he has received non-restricted research grants from the NIHR Oxford BRC, the Quebec Respiratory Health Research Network, the Association Pulmonaire du Québec, the Academy of Medical Sciences, AstraZeneca, bioMérieux, Circassia Niox Group, and Sanofi-Genyme-Regeneron; he is the holder of the Association Pulmonaire du Québec’s Research Chair in Respiratory medicine and is a Clinical research scholar of the Fonds de recherche du Québec; he received speaker honoraria from AstraZeneca, GlaxoSmithKline, Sanofi-Regeneron, Circassia Niox Group and Valeo Pharma; he received consultancy fees for FirstThought, Apogee Therapeutics, Upstream Bio, AstraZeneca, GlaxoSmithKline, Sanofi-Regeneron, Access Biotechnology and Access Industries; he has received sponsorship to attend/speak at international scientific meetings by/for AstraZeneca and Sanofi-Regeneron. He is an advisory board member and detains stock options for Biometry Inc – a company which is developing a FeNO device (myBiometry); he is co-inventor for the patent filed as ‘Method for alleviating dyspnea with neuromodulation’. He advised the Institut national d'excellence en santé et services sociaux (INESSS) for an update of the asthma general practice information booklet for general practitioners as well as therapeutic indications for Enerzair, and is a member of the asthma steering committee of the Canadian Thoracic Society, 2025-05-26

Dr. Sharon Dell: Grants and Research Support: Boehringer Ingelheim, Merck, Parion Sciences, Sanofi, VertexPharmaceuticals; Honoraria or Consultation Fees: AstraZeneca, Novartis, Regeneron Pharmaceuticals Inc., Sanofi



© 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

MAT-GLB-2506512 - 1.0 - 01/2026

MAT-US-2600428 v1.0 - P Expiration Date: 01/16/2028

Número de episodios

28

Último episodio

2026-10-08

¿Donde puedes escuchar?

The latest updates in type 2 inflammatory science, brought to you by leading experts in the field.
The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area.
Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com.
This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals.

©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-GLB-2302644 v2.0 07/2023
MAT-US-2304947 v1.0-P Exp. Date 07/07/2025